• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Resverlogix Corp

+ Add to Watchlist

RFS:GR

0.508 EUR 0.001 0.20%

As of 02:08:12 ET on 07/31/2014.

Snapshot for Resverlogix Corp (RFS)

Open: 0.519 Day's Range: 0.508 - 0.540 Volume: 0
Previous Close: 0.509 52wk Range: 0.259 - 0.732 1-Yr Rtn: +46.82%

Stock Chart for RFS

No chart data available.
  • RFS:GR 0.540
  • 1D
  • 1M
  • 1Y
0.509
Interactive RFS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RFS

Current P/E Ratio (ttm) -
Estimated P/E(04/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (04/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 41.52
Shares Outstanding (M) 81.73
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RFS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RFS

Resverlogix Corp. is a biotechnology company focused on developing therapies for unmet medical needs. The Company concentrates on cardiovascular disease, cancer, and fibrotic conditions.

Donald J McCaffreyPresident/CEO/SecretaryAaron Bradley Cann "Brad"Chief Financial Officer
Norman WongChief Scientific OfficerKenneth LebiodaSenior VP:Bus & Corporate Dev
More Company Profile & Key Executives for RFS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil